{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T04:41:11Z","timestamp":1771562471750,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Korea Health technology R&D Project","award":["A110330"],"award-info":[{"award-number":["A110330"]}]},{"name":"Korea Health technology R&D Project","award":["A110298"],"award-info":[{"award-number":["A110298"]}]},{"name":"Korea Health technology R&D Project","award":["A092258"],"award-info":[{"award-number":["A092258"]}]},{"name":"National R&D Program for Cancer Control","award":["0820040"],"award-info":[{"award-number":["0820040"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.bbrc.2012.04.050","type":"journal-article","created":{"date-parts":[[2012,4,14]],"date-time":"2012-04-14T18:12:48Z","timestamp":1334427168000},"page":"585-590","source":"Crossref","is-referenced-by-count":66,"title":["Valproic acid enhances anti-tumor effect of mesenchymal stem cell mediated HSV-TK gene therapy in intracranial glioma"],"prefix":"10.1016","volume":"421","author":[{"given":"Chung Heon","family":"Ryu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwang Ywel","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong Muk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang Hyun","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Sun","family":"Woo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sin-Soo","family":"Jeun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2012.04.050_b0005","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1023\/A:1006091608586","article-title":"Brain tumor survival: results from the National Cancer Data Base","volume":"40","author":"Surawicz","year":"1998","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.bbrc.2012.04.050_b0010","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/sj.cgt.7700886","article-title":"Genetic strategies for brain tumor therapy","volume":"13","author":"Lawler","year":"2006","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.bbrc.2012.04.050_b0015","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.ejca.2006.01.046","article-title":"Neural stem cells as novel cancer therapeutic vehicles","volume":"42","author":"Yip","year":"2006","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbrc.2012.04.050_b0020","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1349-7006.2005.00032.x","article-title":"Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy","volume":"96","author":"Hamada","year":"2005","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbrc.2012.04.050_b0025","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1089\/hum.1998.9.1-5","article-title":"Bystander effect-mediated therapy of experimental brain tumor by genetically engineered tumor cells","volume":"9","author":"Namba","year":"1998","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.bbrc.2012.04.050_b0030","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1089\/104303400750038499","article-title":"A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme","volume":"11","author":"Rainov","year":"2000","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.bbrc.2012.04.050_b0035","first-page":"347","article-title":"Different effects of valproic acid on proliferation and migration of malignant glioma cells in vitro","volume":"21","author":"Knupfer","year":"2001","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbrc.2012.04.050_b0040","doi-asserted-by":"crossref","first-page":"18030","DOI":"10.1073\/pnas.0408345102","article-title":"Apoptotic and autophagic cell death induced by histone deacetylase inhibitors","volume":"101","author":"Shao","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2012.04.050_b0045","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/cncr.22891","article-title":"Valproic acid for the treatment of myeloid malignancies","volume":"110","author":"Kuendgen","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.bbrc.2012.04.050_b0050","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ctrv.2007.11.003","article-title":"Valproic acid as epigenetic cancer drug: preclinical, clinical and transcriptional effects on solid tumors","volume":"34","author":"Duenas-Gonzalez","year":"2008","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.bbrc.2012.04.050_b0055","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/ijc.24700","article-title":"HDAC inhibitor valproic acid enhances tumor cell kill in adenovirus-HSVtk mediated suicide gene therapy in HNSCC xenograft mouse model","volume":"126","author":"Kothari","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbrc.2012.04.050_b0060","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1089\/hum.2010.187","article-title":"Gene therapy of intracranial glioma using interleukin 12-secreting human umbilical cord blood-derived mesenchymal stem cells","volume":"22","author":"Ryu","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.bbrc.2012.04.050_b0065","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbrc.2010.06.043","article-title":"Migration of human umbilical cord blood mesenchymal stem cells mediated by stromal cell-derived factor-1\/CXCR4 axis via Akt, ERK, and p38 signal transduction pathways","volume":"398","author":"Ryu","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2012.04.050_b0070","first-page":"97","article-title":"CXCR4-transfected human umbilical cord blood-derived mesenchymal stem cells exhibit enhanced migratory capacity toward gliomas","volume":"38","author":"Park","year":"2011","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbrc.2012.04.050_b0075","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1002\/stem.543","article-title":"Irradiation enhances the tumor tropism and therapeutic potential of tumor necrosis factor-related apoptosis-inducing ligand-secreting human umbilical cord blood-derived mesenchymal stem cells in glioma therapy","volume":"28","author":"Kim","year":"2010","journal-title":"Stem cells"},{"key":"10.1016\/j.bbrc.2012.04.050_b0080","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/cgt.2009.64","article-title":"The anti-glioma effect of suicide gene therapy using BMSC expressing HSV\/TK combined with overexpression of Cx43 in glioma cells","volume":"17","author":"Huang","year":"2010","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.bbrc.2012.04.050_b0085","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.canlet.2009.08.028","article-title":"HSV-tk expressing mesenchymal stem cells exert bystander effect on human glioblastoma cells","volume":"290","author":"Matuskova","year":"2010","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2012.04.050_b0090","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/jcb.22554","article-title":"The carboxy-terminal tail of connexin43 gap junction protein is sufficient to mediate cytoskeleton changes in human glioma cells","volume":"110","author":"Crespin","year":"2010","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bbrc.2012.04.050_b0095","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/cgt.2008.49","article-title":"Bystander effect in glioblastoma cells with a predominant cytoplasmic localization of connexin43","volume":"15","author":"Cottin","year":"2008","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.bbrc.2012.04.050_b0100","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bbrc.2004.09.016","article-title":"HDACi phenylbutyrate increases bystander killing of HSV-tk transfected glioma cells","volume":"324","author":"Ammerpohl","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2012.04.050_b0105","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0014-4827(02)00052-6","article-title":"Gap junction-mediated bystander effect in primary cultures of human malignant gliomas with recombinant expression of the HSVtk gene","volume":"284","author":"Asklund","year":"2003","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbrc.2012.04.050_b0110","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.ejca.2003.11.034","article-title":"Histone deacetylase inhibitor 4-phenylbutyrate modulates glial fibrillary acidic protein and connexin 43 expression, and enhances gap-junction communication, in human glioblastoma cells","volume":"40","author":"Asklund","year":"2004","journal-title":"Eur. J Cancer"},{"key":"10.1016\/j.bbrc.2012.04.050_b0115","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0165-0173(99)00099-5","article-title":"Gap junctions: the \u201ckiss of death\u201d and the \u201ckiss of life\u201d","volume":"32","author":"Andrade-Rozental","year":"2000","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.bbrc.2012.04.050_b0120","doi-asserted-by":"crossref","first-page":"9614","DOI":"10.1158\/0008-5472.CAN-08-0451","article-title":"Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma","volume":"68","author":"Kim","year":"2008","journal-title":"Cancer Res."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X12006997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X12006997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,24]],"date-time":"2018-11-24T03:55:30Z","timestamp":1543031730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X12006997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0006291X12006997"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2012.04.050","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}